EDGAR Filing Agent Form List
CIK: 0001306923
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Revance Therapeutics, Inc. | 02/13/2025 | |||
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Karyopharm Therapeutics Inc. | 02/14/2024 | |
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Ehealth, Inc. | 02/14/2024 | |
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Revance Therapeutics, Inc. | 02/14/2024 | |
| SC 13G/A | Insmed Inc | Amendment to Schedule filed to report acquisition of b... | 02/14/2023 | ||
| SC 13G/A | Alimera Sciences Inc | Amendment to Schedule filed to report acquisition of b... | 02/14/2023 | ||
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Revance Therapeutics, Inc. | 02/14/2023 | |
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Karyopharm Therapeutics Inc. | 02/14/2023 | |
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Ehealth, Inc. | 02/14/2023 | |
| SC 13G/A | Palo Alto Investors Lp | Amendment to Schedule filed to report acquisition of b... | Epizyme, Inc. | 02/14/2023 | |
| Load More | |||||
